Conditions Treated
- Autoimmune Lung Diseases
- Connective Tissue Disease – Associated Interstitial Lung Disease
- Lupus (Systemic Lupus Erythematosus)
- Rheumatoid Arthritis
- Systemic Sclerosis (Scleroderma)
- Systemic Vasculitis
Research Areas
- Autoimmune Lung Diseases
- Connective Tissue Disease – Associated Interstitial Lung Disease
- Systemic Sclerosis
- Gender:
- Male
Education & Training
Education
- 1994-1998
- University of Maryland School of Medicine, MD
Residency
- 1998-2001
- Temple University Hospital, Internal Medicine Internship and Residency
- 2001-2002
- Temple University Hospital, Chief Medical Resident
Fellowship
- 2002-2004
- University of Colorado Denver, Rheumatology Fellowship
Special Interests
Research Interests
Dr. Aryeh Fischer is Acting Chief of Rheumatology, co-Director of the Autoimmune Lung Center, and Associate Professor of Medicine at National Jewish Health. Dr. Fischer has strong clinical and research interests involving autoimmune lung disease and connective tissue disease associated - interstitial lung disease and pulmonary arterial hypertension in particular. Dr. Fischer has served as an invited lecturer on autoimmune lung disease at numerous national and international medical conferences and has published numerous original research articles, review articles and textbook chapters within these arenas. Dr. Fischer also has clinical interests in other systemic autoimmune diseases, and systemic sclerosis (scleroderma) in particular.
Board Certification
2004: American Board of Internal Medicine in Rheumatology
2001: American Board of Internal Medicine
Teaching or Professional Positions
Associate Professor of Medicine, Division of Rheumatology, Department of Medicine, National Jewish Health
Industry Relationships & Collaborations
National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations.
Affiliations with the University of Colorado Denver
Director, Scleroderma Clinic, University of Colorado.
Professional Memberships
American College of Rheumatology
American Thoracic Society
Scleroderma Foundation: Medical Advisory Board Member
Pulmonary Fibrosis Foundation: Medical Advisory Board Member
Publications
Fischer A, Interstitial Lung Disease: A Rheumatologist’s Perspective. Journal of Clinical Rheumatology 2009. 15(2):95-99.
Fischer A, Swigris JJ, West SG, Brown KK, du Bois R M. Connective Tissue Disease Associated Interstitial Lung Disease: A call for clarification. Chest 2010;138 251-256.
Fischer A, Solomon JJ, du Bois RM, Deane KD, Olson AL, Fernandez-Perez ER, Huie TJ, Stevens AD, Gill MB, Rabinovitch AM, Lynch DA, Burns DA, Pineiro IS, Groshong SD, Duarte Achcar RD, Brown KK, Martin RJ, Swigris JJ. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respiratory Medicine. 2012 Jul;106(7):1040-7.
Fischer A, Bull TM, Steen VD. A practical approach to screening for scleroderma-associated pulmonary arterial hypertension. Arthritis Care Research. 2012 ; 64 (3):303–310.
Fischer A & du Bois RM. Interstitial Lung Disease in Connective Tissue Disorders: Prognosis and Therapeutic Dilemmas. The Lancet. In Press.
More Publications by This Author
Link to PubMed for more papers
